Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 10, 2011, Pages 1153-1163

  Koth, Laura L ^a   Solberg, Owen D ^b   Peng, Jeffrey C ^b   Bhakta, Nirav R ^a   Nguyen, Christine P ^a   Woodruff, Prescott G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Algorithms; Computational biology; Gene expression profiling; Interferons

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD TRANSCRIPTOME ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG SARCOIDOSIS; LUNG TUBERCULOSIS; MACHINE LEARNING; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTOMICS;

ALGORITHMS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; LUNG; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX; TRANSCRIPTOME; TUBERCULOSIS, PULMONARY;

EID: 81455150139     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201106-1143OC     Document Type: Article

References (48)

1. Siltzbach LE, James DG, Neville E, Turiaf J, Battesti JP, Sharma OP, Hosoda Y, Mikami R, Odaka M. Course and prognosis of sarcoidosis around the world. Am J Med 1974;57:847-852.
2. James DG. Immunology of sarcoidosis. Lancet 1966;2:633-635.
3. Sones M, Israel HL. Altered immunologic reactions in sarcoidosis. Ann Intern Med 1954;40:260-268.
4. Hudspith BN, Flint KC, Geraint-James D, Brostoff J, Johnson NM. Lack of immune deficiency in sarcoidosis: compartmentalisation of the immune response. Thorax 1987;42:250-255. (Pubitemid 17058937)
5. Hirschhorn K, Schreibman RR, Bach FH, Siltzbach LE. In-vitro studies of lymphocytes from patients with sarcoidosis and lymphoproliferative diseases. Lancet 1964;2:842-843.
6. Sharma OP, James DG, Fox RA. A correlation of in vivo delayed-type hypersensitivity with in vitro lymphocyte transformation in sarccidosis. Chest 1971;60:35-37.
7. Kataria YP, Sagone AL, LoBuglio AG, Bromberg PA. In vitro observations on sarcoid lymphocytes and their correlation with cutaneous energy and clinical severity of disease. Am Rev Respir Dis 1973;108:767-776.
8. Robinson BW, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985;75:1488-1495. (Pubitemid 15041440)
9. Greene CM, Meachery G, Taggart CC, Rooney CP, Coakley R, O'Neill SJ, McElvaney NG. Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J Immunol 2000;165:4718-4724.
10. Muller-Quernheim J, Saltini C, Sondermeyer P, Crystal RG. Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis. J Immunol 1986;137:3475-3483. (Pubitemid 17193303)
11. Crystal RG, Roberts WC, Hunninghake GW, Gadek JE, Fulmer JD, Line BR. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med 1981;94:73-94. (Pubitemid 11218737)
12. Hunninghake GW, Gadek JE, Young RC Jr, Kawanami O, Ferrans VJ, Crystal RG. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med 1980;302:594-598. (Pubitemid 10073407)
13. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981;305:429-434. (Pubitemid 11047044)
14. Daniele RP, Dauber JH, Rossman MD. Immunologic abnormalities in sarcoidosis. Ann Intern Med 1980;92:406-416. (Pubitemid 10150477)
15. Costabel U, Bross KJ, Ruhle KH, Lohr GW, Matthys H. Ia-like antigens on T-cells and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis: analysis of bronchoalveolar and blood lymphocytes. Am Rev Respir Dis 1985;131:337-342. (Pubitemid 15133589)
16. Saltini C, Spurzem JR, Lee JJ, Pinkston P, Crystal RG. Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the leu3+dr+ T cell subset. J Clin Invest 1986;77:1962-1970. (Pubitemid 16062653)
17. Rossi GA, Sacco O, Cosulich E, Risso A, Balbi B, Ravazzoni C. Helper T-lymphocytes in pulmonary sarcoidosis: functional analysis of a lung T-cell subpopulation in patients with active disease. Am Rev Respir Dis 1986;133:1086-1090. (Pubitemid 16090017)
18. Saltini C, Hemler ME, Crystal RG. T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex vla-1. Clin Immunol Immunopathol 1988;46:221-233.
19. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983;308:793-800. (Pubitemid 13114673)
20. Hunninghake GW, Bedell GN, Zavala DC, Monick M, Brady M. Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis. Am Rev Respir Dis 1983;128:634-638. (Pubitemid 13014111)
21. Hunninghake GW, Crystal RG. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis: site of increased antibody production and role of T lymphocytes. J Clin Invest 1981;67:86-92. (Pubitemid 11163160)
22. Barnard J, Rose C, Newman L, Canner M, Martyny J, McCammon C, Bresnitz E, Rossman M, Thompson B, Rybicki B, et al. Job and industry classifications associated with sarcoidosis in a case-control etiologic study of sarcoidosis (access). J Occup Environ Med 2005;47:226-234. (Pubitemid 40365760)
23. Chen ES, Moller DR. Etiology of sarcoidosis. Clin Chest Med 2008;29:365-377 (vii). (Pubitemid 351778206)
24. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, Terrin ML, Weinberger SE, Moller DR, McLennan G, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004;170:1324-1330. (Pubitemid 39657197)
25. Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R, Newman LS, Kalams SA. Cellular recognition of mycobacterium tuberculosis ESAT-6 and KATG peptides in systemic sarcoidosis. Infect Immun 2007;75:527-530. (Pubitemid 46047932)
26. Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 2007;30:508-516. (Pubitemid 351182075)
27. Klemen H, Husain AN, Cagle PT, Garrity ER, Popper HH. Mycobacterial DNA in recurrent sarcoidosis in the transplanted lung: a PCR-based study on four cases. Virchows Arch 2000;436:365-369. (Pubitemid 30219235)
28. Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005;201:755-767. (Pubitemid 40395121)
29. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010;466:973-977.
30. Woodruff PG, Solberg OD, Snyder-Cappione JE, Hou L, Nguyen C, Chi J, Koth LL. Whole blood gene expression analysis identifies sarcoidosis-specific markers including decreased IL7 receptor expression. Am J Respir Crit Care Med 2010;181:A3981.
31. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (Ers) and the World Association of Sarcoidosis and other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-755.
32. Rosenbaum JT, Pasadhika S, Crouser ED, Choi D, Harrington CA, Lewis JA, Austin CR, Diebel TN, Vance EE, Braziel RM, et al. Hypothesis: sarcoidosis is a STAT1-mediated disease. Clin Immunol 2009;132:174-183.
33. Winterbauer RH, Belic N, Moores KD. Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 1973;78:65-71.
34. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, Baldwin N, Stichweh D, Blankenship D, Li L, Munagala I, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 2008;29:150-164. (Pubitemid 351952461)
35. Crouser ED, Culver DA, Knox KS, Julian MW, Shao G, Abraham S, Liyanarachchi S, Macre JE, Wewers MD, Gavrilin MA, et al. Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am J Respir Crit Care Med 2009;179:929-938.
36. Lockstone HE, Sanderson S, Kulakova N, Baban D, Leonard A, Kok WL, McGowan S, McMichael AJ, Ho LP. Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis. Am J Respir Crit Care Med 2010;181:1367-1375.
37. Diaz-Uriarte R, Alvarez de Andres S. Gene selection and classification of microarray data using random forest. BMC Bioinformatics 2006;7:3.
38. Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc, B 2005;67:310-320.
39. Dabney AR. Classification of microarrays to nearest centroids. Bioinformatics 2005;21:4148-4154. (Pubitemid 41672105)
40. Liaw A, Wiener M. Classification and regression by randomforest. R News 2002;2:18-22.
41. Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S, Ellwanger A, Sidhu SS, Dao-Pick TP, Pantoja C, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA 2007;104:15858-15863. (Pubitemid 350035389)
42. Dolganov GM, Woodruff PG, Novikov AA, Zhang Y, Ferrando RE, Szubin R, Fahy JV. A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+-K+-Cl- cotransporter (nkcc1) in asthmatic subjects. Genome Res 2001;11:1473-1483. (Pubitemid 32894673)
43. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
44. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser A Stat Soc 2005;57:289-300.
45. Wahlstrom J, Katchar K, Wigzell H, Olerup O, Eklund A, Grunewald J. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med 2001;163:115-121. (Pubitemid 32097972)
46. Konishi K, Moller DR, Saltini C, Kirby M, Crystal RG. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis. J Clin Invest 1988;82:775-781.
47. Schwarz MI, King TE. Interstitial lung disease. BC Decker; Hamilton, Ontario, Canada: 1998.
48. Hunninghake GW, Fulmer JD, Young RC Jr, Gadek JE, Crystal RG. Localization of the immune response in sarcoidosis. Am Rev Respir Dis 1979;120:49-57. (Pubitemid 9248768)